Literature DB >> 7706167

Nucleotide sequence and genetic analysis of the type Ib trimethoprim-resistant, Tn4132-encoded dihydrofolate reductase.

H K Young1, M J Qumsieh, M L McIntosh.   

Abstract

Transposon Tn4132, encoding the type Ib trimethoprim-resistant, dihydrofolate reductase, was transposed from the clinical plasmid pUK163 to a small recombinant plasmid pZMR12. Restriction endonuclease and partial sequence analysis of Tn4132 revealed a close relationship to Tn7. The nucleotide sequence of the dhfrIb trimethoprim-resistance gene was determined and the gene and its product were found to share significant homology with the dhfrIa, V, VI and VII plasmid-encoded dihydrofolate reductases. Extensive sequence homology (88%) was observed with the type V dihydrofolate reductase at both the nucleotide and amino acid level. Oligonucleotide probes, distinguishing between the dhfrIb and dhfrV genes, were designed. The discriminatory capabilities of these probes in future epidemiological studies will permit a more accurate determination of the dissemination of these two closely related trimethoprim-resistance genes than has previously been possible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7706167     DOI: 10.1093/jac/34.5.715

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron.

Authors:  P V Adrian; C J Thomson; K P Klugman; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Identification of a complete dfrA14 gene cassette integrated at a secondary site in a resistance plasmid of uropathogenic Escherichia coli from Nigeria.

Authors:  Kayode K Ojo; Corinna Kehrenberg; Stefan Schwarz; H Akin Odelola
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Erythromycin esterase gene ere(A) is located in a functional gene cassette in an unusual class 2 integron.

Authors:  Latefa Biskri; Didier Mazel
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

4.  Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy.

Authors:  V Falbo; A Carattoli; F Tosini; C Pezzella; A M Dionisi; I Luzzi
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

5.  Novel rearrangement of a class 2 integron in two non-epidemiologically related isolates of Acinetobacter baumannii.

Authors:  María Soledad Ramírez; Cecilia Quiroga; Daniela Centrón
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  New trimethoprim-resistant dihydrofolate reductase cassette, dfrXV, inserted in a class 1 integron.

Authors:  P V Adrian; M DU Plessis; K P Klugman; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Large conjugative plasmids from clinical strains of Salmonella enterica serovar virchow contain a class 2 integron in addition to class 1 integrons and several non-integron-associated drug resistance determinants.

Authors:  Irene Rodríguez; M Rosario Rodicio; M Carmen Mendoza; M Cruz Martín
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 8.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

9.  IntI2 integron integrase in Tn7.

Authors:  Karin Hansson; Lars Sundström; Alex Pelletier; Paul H Roy
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

10.  Prevalence and genetic location of non-transferable trimethoprim resistant dihydrofolate reductase genes in South African commensal faecal isolates.

Authors:  P V Adrian; C J Thomson; K P Klugman; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.